Literature DB >> 33718878

Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawai'i Reveals the Worldwide Emerging P681H Mutation.

David P Maison1,2, Lauren L Ching1,2, Cecilia M Shikuma1,3, Vivek R Nerurkar1,2.   

Abstract

The COVID-19 pandemic has ravaged the world, caused over 1.8 million deaths in its first year, and severely affected the global economy. Hawai'i has not been spared from the transmission of SARS-CoV-2 in the local population, including high infection rates in racial and ethnic minorities. Early in the pandemic, we described in this journal various technologies used for the detection of SARS-CoV-2. Herein we characterize a 969-bp SARS-CoV-2 segment of the S gene downstream of the receptor-binding domain. At the John A. Burns School of Medicine Biocontainment Facility, RNA was extracted from an oropharyngeal swab and a nasal swab from 2 patients from Hawai'i who were infected with SARS-CoV-2 in August 2020. Following PCR, the 2 viral strains were sequenced using Sanger sequencing, and phylogenetic trees were generated using MEGAX. Phylogenetic tree results indicate that the virus has been introduced to Hawai'i from multiple sources. Further, we decoded 13 single nucleotide polymorphisms across 13 unique SARS-CoV-2 genomes within this region of the S gene, with 1 non-synonymous mutation (P681H) found in the 2 Hawai'i strains. The P681H mutation has unique and emerging characteristics with a significant exponential increase in worldwide frequency when compared to the plateauing of the now universal D614G mutation. The P681H mutation is also characteristic of the new SARS-CoV-2 variants from the United Kingdom and Nigeria. Additionally, several mutations resulting in cysteine residues were detected, potentially resulting in disruption of the disulfide bridges in and around the receptor-binding domain. Targeted sequence characterization is warranted to determine the origin of multiple introductions of SARS-CoV-2 circulating in Hawai'i. ©Copyright 2021 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  Hawai‘i strains; S gene; genomic characterization; phylogenetic tree; proline; single nucleotide polymorphism; spike protein; variant

Year:  2021        PMID: 33718878      PMCID: PMC7953241     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  27 in total

1.  A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.

Authors:  M Donoghue; F Hsieh; E Baronas; K Godbout; M Gosselin; N Stagliano; M Donovan; B Woolf; K Robison; R Jeyaseelan; R E Breitbart; S Acton
Journal:  Circ Res       Date:  2000-09-01       Impact factor: 17.367

2.  Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity.

Authors:  Mark Yarmarkovich; John M Warrington; Alvin Farrel; John M Maris
Journal:  Cell Rep Med       Date:  2020-06-08

Review 3.  Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses.

Authors:  Shuo Su; Gary Wong; Weifeng Shi; Jun Liu; Alexander C K Lai; Jiyong Zhou; Wenjun Liu; Yuhai Bi; George F Gao
Journal:  Trends Microbiol       Date:  2016-03-21       Impact factor: 17.079

4.  Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Province, China.

Authors:  Yuan Yuan; Jun He; Lei Gong; Weiwei Li; Liangliang Jiang; Jiang Liu; Qingqing Chen; Junling Yu; Sai Hou; Yonglin Shi; Siqi Lu; Zhuhui Zhang; Yinglu Ge; Nan Sa; Lan He; Jiabing Wu; Yong Sun; Zhirong Liu
Journal:  BMC Infect Dis       Date:  2020-12-07       Impact factor: 3.090

5.  The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.

Authors:  Qianqian Li; Jiajing Wu; Jianhui Nie; Li Zhang; Huan Hao; Shuo Liu; Chenyan Zhao; Qi Zhang; Huan Liu; Lingling Nie; Haiyang Qin; Meng Wang; Qiong Lu; Xiaoyu Li; Qiyu Sun; Junkai Liu; Linqi Zhang; Xuguang Li; Weijin Huang; Youchun Wang
Journal:  Cell       Date:  2020-07-17       Impact factor: 41.582

Review 6.  Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.

Authors:  Yuan Huang; Chan Yang; Xin-Feng Xu; Wei Xu; Shu-Wen Liu
Journal:  Acta Pharmacol Sin       Date:  2020-08-03       Impact factor: 6.150

7.  Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.

Authors:  Bas B Oude Munnink; Reina S Sikkema; David F Nieuwenhuijse; Robert Jan Molenaar; Emmanuelle Munger; Richard Molenkamp; Arco van der Spek; Paulien Tolsma; Ariene Rietveld; Miranda Brouwer; Noortje Bouwmeester-Vincken; Frank Harders; Renate Hakze-van der Honing; Marjolein C A Wegdam-Blans; Ruth J Bouwstra; Corine GeurtsvanKessel; Annemiek A van der Eijk; Francisca C Velkers; Lidwien A M Smit; Arjan Stegeman; Wim H M van der Poel; Marion P G Koopmans
Journal:  Science       Date:  2020-11-10       Impact factor: 47.728

Review 8.  COVID-19 vaccines: The status and perspectives in delivery points of view.

Authors:  Jee Young Chung; Melissa N Thone; Young Jik Kwon
Journal:  Adv Drug Deliv Rev       Date:  2020-12-24       Impact factor: 17.873

9.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

View more
  20 in total

1.  Emergence of the First Strains of SARS-CoV-2 Lineage B.1.1.7 in Romania: Genomic Analysis.

Authors:  Andrei Lobiuc; Mihai Dimian; Olga Sturdza; Roxana Filip; Mihai Covasa
Journal:  JMIRx Med       Date:  2021-08-13

2.  Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.

Authors:  Seung Bum Park; Parker Irvin; Zongyi Hu; Mohsin Khan; Xin Hu; Qiru Zeng; Catherine Chen; Miao Xu; Madeleine Leek; Ruochen Zang; James Brett Case; Wei Zheng; Siyuan Ding; T Jake Liang
Journal:  mBio       Date:  2022-01-11       Impact factor: 7.867

3.  Rescuing the Host Immune System by Targeting the Immune Evasion Complex ORF8-IRF3 in SARS-CoV-2 Infection with Natural Products Using Molecular Modeling Approaches.

Authors:  Aqel Albutti
Journal:  Int J Environ Res Public Health       Date:  2021-12-23       Impact factor: 3.390

Review 4.  Covid-19 vaccines and variants of concern: A review.

Authors:  Ikbel Hadj Hassine
Journal:  Rev Med Virol       Date:  2021-11-09       Impact factor: 11.043

5.  Genomic surveillance of SARS-CoV-2 in the state of Delaware reveals tremendous genomic diversity.

Authors:  Karl R Franke; Robert Isett; Alan Robbins; Carrie Paquette-Straub; Craig A Shapiro; Mary M Lee; Erin L Crowgey
Journal:  PLoS One       Date:  2022-01-19       Impact factor: 3.240

6.  Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020-March 2021) Using a Statistical Learning Strategy.

Authors:  Lue Ping Zhao; Terry P Lybrand; Peter B Gilbert; Thomas R Hawn; Joshua T Schiffer; Leonidas Stamatatos; Thomas H Payne; Lindsay N Carpp; Daniel E Geraghty; Keith R Jerome
Journal:  Viruses       Date:  2021-12-21       Impact factor: 5.818

Review 7.  Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.

Authors:  Jatin Chadha; Lavanya Khullar; Nidhi Mittal
Journal:  Environ Microbiol       Date:  2021-08-08       Impact factor: 5.476

Review 8.  SARS-CoV-2: is there neuroinvasion?

Authors:  Conor McQuaid; Molly Brady; Rashid Deane
Journal:  Fluids Barriers CNS       Date:  2021-07-14

9.  Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.

Authors:  Abdou Nagy; Shereen Basiouni; Rokshana Parvin; Hafez M Hafez; Awad A Shehata
Journal:  Arch Virol       Date:  2021-07-13       Impact factor: 2.574

10.  Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 - 2021/03) Using a Statistical Learning Strategy.

Authors:  Lue Ping Zhao; Terry P Lybrand; Peter B Gilbert; Thomas R Hawn; Joshua T Schiffer; Leonidas Stamatatos; Thomas H Payne; Lindsay N Carpp; Daniel E Geraghty; Keith R Jerome
Journal:  bioRxiv       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.